Advertisement
Singapore markets open in 3 hours 50 minutes
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Bitcoin USD

    66,351.52
    -137.23 (-0.21%)
     
  • CMC Crypto 200

    1,426.91
    +12.15 (+0.86%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Gold

    2,335.70
    -10.70 (-0.46%)
     
  • Crude Oil

    83.40
    +1.50 (+1.83%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    -7,073.82 (-49.87%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Hyflux has at least seven non-binding offers as cash runs out

Hyflux's Tuaspring power plant. (PHOTO: Hyflux)
Hyflux Ltd., which was put under judicial management in November last year, currently has at least seven non-binding offers from potential investors. (PHOTO: Hyflux)

By Ameya Karve

(Bloomberg) —Hyflux Ltd., which was put under judicial management in November last year, will be fielding several possible bids in the months ahead as it tries to avoid running out of money.

The Singaporean water-treatment company currently has at least seven non-binding offers from potential investors, according to two people familiar with the matter. It needs to move fast: the firm had S$18.4 million ($13.8 million) of cash as of Jan. 31, enough to survive five months from that date, the people said, asking not to be identified because the matter is private.

The suitors have shown interest in Hyflux as a whole or for some of its assets, but the bids have varying degrees of complexity and many need additional clarification, the people said.

ADVERTISEMENT

Patrick Bance, a Singapore-based director at Hyflux’s judicial manager Borrelli Walsh, declined to comment.

Once a corporate highflyer, Hyflux is Singapore’s most high-profile debt-restructuring case that has dragged on since a court-supervised process began in May 2018. Rapidly declining liquidity is adding to the woes: its cash and equivalents halved for two straight years through 2020; read for more details.

Borrelli Walsh isn’t yet able to determine whether the company will be restructured in entirety or its assets will be sold piecemeal, according to the people.

The judicial manager seeks binding offers from suitors by March 31 and targets finalizing the term sheets with shortlisted investors by April 15, the people said.

Among the group’s main operating entities, Hydrochem (S) Pte held the most cash, while Hyflux Engineering Pte and Hyflux Membrane Manufacturing (S) Pte had at least S$2.8 million as of Jan. 31, according to the people.

Entity

Cash (in millions)

Hyflux

S$2.6

Hydrochem (S) Pte

S$9.1

Hyflux Engineering

S$3.9

Hyflux Membrane

S$2.8

Total

S$18.4

In January this year, Hyflux said 17 potential investors were conducting due diligence for submitting non-binding offers and the judicial manager would invite shortlisted suitors to participate in second stage of bidding process on or about Feb. 15.

(Adds details on cash position of main entities in eighth paragraph.)

© 2021 Bloomberg L.P.